New Stock Futures Listings: FIG, IONS, FRMI and BOT USDT-M Futures to Launch on Jul 13 with 0-Fee Trading

To further expand trading opportunities and enhance your Futures trading experience, MEXC will launch FIG, IONS, FRMI and BOT USDT-M Stock Futures on the Futures market. These new listings offer a flexible and efficient way to gain exposure to some of the most prominent equities. Futures trading will be available immediately upon listing, with Futures Grid Bot strategies available within 5 minutes of listing.


Futures Trading Details

Feature
Details
Details
Details
Details
Trading Pair
FIGUSDTIONSUSDTFRMIUSDTBOTUSDT
Listing Time
Jul 13, 2026, 10:50 (UTC)Jul 13, 2026, 10:50 (UTC)Jul 13, 2026, 10:50 (UTC)Jul 13, 2026, 10:50 (UTC)
Max Leverage
20x20x20x20x
Margin Mode
Cross & Isolated
Cross & Isolated
Cross & Isolated
Cross & Isolated
Trading Hours
24/7
24/7
24/7
24/7

Introduction

FIG: Figma, Inc. develops a browser-based tool for designing user interfaces that helps design and development teams build various products. The company offers Figma Design, a collaborative design tool for teams that explore ideas and gather feedback, build realistic prototypes, and streamline product development with design systems; Dev Mode to inspect designs and translate them into code without changing the design file; FigJam to define ideas, align on decisions, and move work forward & all in one place; and Figma Slides, a presentation tool built for designers and their teams.

IONS: Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and Biogen brought Spinraza to market in 2016 as a treatment for spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024. Ionis marked its first two independent launches in 2025 for Tryngolza (for FCS) and Dawnzera (for HAE).

FRMI: Fermi Inc building a private power campus for AI-centric customers, developing and leasing large-scale, grid-independent energy generation and high-performance computing facilities purpose-built for the hyperscale era. The company is also developing a private energy and site infrastructure platform across the campus to support multiple powered shell buildings and a diversified, integrated power supply, including private power generation and delivery infrastructure, substations, internal distribution networks, water and cooling systems, and other essential infrastructure. In addition to powered shell facilities, it may offer long-term ground leases to tenants that elect to construct their own powered shell facilities on land, with or without integrated power delivery.

BOT: BOT tracks the value of 1 share of common stock in RoboStrategy, Inc. RoboStrategy is a publicly listed closed-end investment company focused on robotics and embodied artificial intelligence, investing in equity and equity-linked securities of private and public companies across robotics, humanoid systems, and physical AI.


🎉 Limited-Time Offer: Enjoy 0 Trading Fees

Enjoy 0 trading fees on the Stock Futures for a limited time! This fee update only applies to select users in specific regions. Please check your account's fee page or trading page for the latest rates.

Related Articles:

Important Notes
• Corporate actions (e.g., dividends, stock splits, reverse splits) may cause sharp price movements. Depending on market conditions, the platform may implement measures including early settlement or position adjustments. Users should monitor relevant announcements and manage risks to avoid unexpected losses.
• Stocks may trigger a circuit breaker due to market conditions. If triggered, trading will be halted and orders cannot be executed. No liquidation will occur, and existing orders can still be canceled. Please monitor the market, manage your positions, and refer to the official circuit breaker announcement for details.
• Availability of Stock Futures may vary by region due to regulatory restrictions. Certain jurisdictions may not support these products. Please refer to the User Agreement for full details.
• MEXC reserves the right to adjust the list of supported regions at any time based on operational and compliance considerations.
Coin Icon
Sign up now to receive 10,000 USDT in new user rewards

Subscribe to MEXC Digest

Weekly market moves, listings & insights, straight to your inbox.
By subscribing, you agree to receive MEXC newsletters and email updates, and to our Privacy Policy. The content provided is for informational purposes only and does not constitute investment advice.

Join MEXC on Telegram

Get the latest listings, events, and updates in real time, straight from our official Telegram channel.

New Stock Futures Listings: FIG, IONS, FRMI and BOT USDT-M Futures to Launch on Jul 13 with 0-Fee Trading

To further expand trading opportunities and enhance your Futures trading experience, MEXC will launch FIG, IONS, FRMI and BOT USDT-M Stock Futures on the Futures market. These new listings offer a flexible and efficient way to gain exposure to some of the most prominent equities. Futures trading will be available immediately upon listing, with Futures Grid Bot strategies available within 5 minutes of listing.


Futures Trading Details

Feature
Details
Details
Details
Details
Trading Pair
FIGUSDTIONSUSDTFRMIUSDTBOTUSDT
Listing Time
Jul 13, 2026, 10:50 (UTC)Jul 13, 2026, 10:50 (UTC)Jul 13, 2026, 10:50 (UTC)Jul 13, 2026, 10:50 (UTC)
Max Leverage
20x20x20x20x
Margin Mode
Cross & Isolated
Cross & Isolated
Cross & Isolated
Cross & Isolated
Trading Hours
24/7
24/7
24/7
24/7

Introduction

FIG: Figma, Inc. develops a browser-based tool for designing user interfaces that helps design and development teams build various products. The company offers Figma Design, a collaborative design tool for teams that explore ideas and gather feedback, build realistic prototypes, and streamline product development with design systems; Dev Mode to inspect designs and translate them into code without changing the design file; FigJam to define ideas, align on decisions, and move work forward & all in one place; and Figma Slides, a presentation tool built for designers and their teams.

IONS: Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and Biogen brought Spinraza to market in 2016 as a treatment for spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024. Ionis marked its first two independent launches in 2025 for Tryngolza (for FCS) and Dawnzera (for HAE).

FRMI: Fermi Inc building a private power campus for AI-centric customers, developing and leasing large-scale, grid-independent energy generation and high-performance computing facilities purpose-built for the hyperscale era. The company is also developing a private energy and site infrastructure platform across the campus to support multiple powered shell buildings and a diversified, integrated power supply, including private power generation and delivery infrastructure, substations, internal distribution networks, water and cooling systems, and other essential infrastructure. In addition to powered shell facilities, it may offer long-term ground leases to tenants that elect to construct their own powered shell facilities on land, with or without integrated power delivery.

BOT: BOT tracks the value of 1 share of common stock in RoboStrategy, Inc. RoboStrategy is a publicly listed closed-end investment company focused on robotics and embodied artificial intelligence, investing in equity and equity-linked securities of private and public companies across robotics, humanoid systems, and physical AI.


🎉 Limited-Time Offer: Enjoy 0 Trading Fees

Enjoy 0 trading fees on the Stock Futures for a limited time! This fee update only applies to select users in specific regions. Please check your account's fee page or trading page for the latest rates.

Related Articles:

Important Notes
• Corporate actions (e.g., dividends, stock splits, reverse splits) may cause sharp price movements. Depending on market conditions, the platform may implement measures including early settlement or position adjustments. Users should monitor relevant announcements and manage risks to avoid unexpected losses.
• Stocks may trigger a circuit breaker due to market conditions. If triggered, trading will be halted and orders cannot be executed. No liquidation will occur, and existing orders can still be canceled. Please monitor the market, manage your positions, and refer to the official circuit breaker announcement for details.
• Availability of Stock Futures may vary by region due to regulatory restrictions. Certain jurisdictions may not support these products. Please refer to the User Agreement for full details.
• MEXC reserves the right to adjust the list of supported regions at any time based on operational and compliance considerations.
Coin Icon
Sign up now to receive 10,000 USDT in new user rewards

Subscribe to MEXC Digest

Weekly market moves, listings & insights, straight to your inbox.
By subscribing, you agree to receive MEXC newsletters and email updates, and to our Privacy Policy. The content provided is for informational purposes only and does not constitute investment advice.

Join MEXC on Telegram

Get the latest listings, events, and updates in real time, straight from our official Telegram channel.
Stay up-to-date on the latest MEXC listings, delistings, trading events, and product updates. Discover new tokens, Launchpad projects, Earn opportunities, AI-powered tools, and futures trading enhancements on the MEXC platform.Stay up-to-date on the latest MEXC listings, delistings, trading events, and product updates. Discover new tokens, Launchpad projects, Earn opportunities, AI-powered tools, and futures trading enhancements on the MEXC platform.